Total assets fell 19% to $73.1B as goodwill dropped 35% to $19.7B, but debt remains substantial at $19.0B with a D/E of 0.53 that understates true leverage given $13.5B in cumulative impairments reducing equity.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Total Current Assets | 9.25B | 10.13B | 7.66B | 7.93B | 7.9B | 8.99B | 10.82B | 8.1B | 9.07B | 7.2B | 8.75B | 9.78B | 4.79B | 4.91B | 4.82B | 3.27B |
| Cash & Short-Term Investments | 2.68B | 3.67B | 1.33B | 1.4B | 1.04B | 3.44B | 3.42B | 2.28B | 1.13B | 1.63B | 4.2B | 4.84B | 1.29B | 1.69B | 1.25B | 0 |
| Cash Only | 2.42B | 2.62B | 1.33B | 1.4B | 1.04B | 3.44B | 3.42B | 2.28B | 1.13B | 1.63B | 4.2B | 4.84B | 1.29B | 1.69B | 1.25B | 0 |
| Short-Term Investments | 262M | 1.06B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.29B | 2.25B | 2.15B | 2.11B | 2.12B | 1.96B | 2.06B | 1.97B | 2.28B | 1.81B | 1.16B | 1.45B | 1.08B | 1.05B | 1.09B | 903M |
| Days Sales Outstanding | 33.35 | 32.98 | 30.32 | 28.94 | 29.22 | 27.43 | 28.76 | 28.83 | 31.7 | 25.36 | 16.07 | 28.94 | 21.65 | 21 | 21.75 | 17.74 |
| Inventory | 3.31B | 3.17B | 3.38B | 3.61B | 3.65B | 2.73B | 2.77B | 2.72B | 2.67B | 2.76B | 2.68B | 2.62B | 1.77B | 1.62B | 1.93B | 1.94B |
| Days Inventory Outstanding | 72.64 | 69.5 | 73.01 | 74.47 | 72.57 | 57.38 | 59.51 | 59.01 | 56.12 | 59.11 | 57.11 | 75.98 | 48.49 | 51.76 | 56.3 | 55.35 |
| Other Current Assets | 710M | 740M | 583M | 569M | 846M | 727M | 2.44B | 740M | 2.6B | 655M | 707M | 871M | 643M | 558M | 551M | 426M |
| Total Non-Current Assets | 63.81B | 71.66B | 80.63B | 82.41B | 82.62B | 84.4B | 89.01B | 93.35B | 94.39B | 112.89B | 111.73B | 113.19B | 18.16B | 18.24B | 18.36B | 18.27B |
| Property, Plant & Equipment | 7.2B | 7.32B | 7.15B | 7.12B | 6.74B | 6.81B | 6.88B | 7.05B | 7.08B | 7.06B | 6.69B | 6.52B | 4.19B | 4.12B | 4.2B | 4.28B |
| Fixed Asset Turnover | 3.45x | 3.41x | 3.61x | 3.74x | 3.93x | 3.83x | 3.81x | 3.54x | 3.71x | 3.69x | 3.93x | 2.81x | 4.34x | 4.43x | 4.35x | 4.34x |
| Goodwill | 19.71B | 22.18B | 28.67B | 30.46B | 30.83B | 31.3B | 33.09B | 35.55B | 36.5B | 44.83B | 44.13B | 43.05B | 11.4B | 11.51B | 11.6B | 11.32B |
| Intangible Assets | 32.37B | 37.53B | 40.1B | 42.45B | 42.65B | 43.54B | 46.67B | 48.65B | 49.47B | 59.43B | 59.3B | 62.12B | 2.23B | 2.23B | 2.23B | 2.63B |
| Long-Term Investments | 167M | 0 | 196M | 112M | 108M | 182M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.53B | 4.63B | 4.51B | 2.27B | 2.29B | 2.57B | 2.38B | 2.1B | 1.34B | 1.57B | 1.62B | 1.5B | 326M | 391M | 325M | 43M |
| Total Assets | 73.06B | 81.79B | 88.29B | 90.34B | 90.51B | 93.39B | 99.83B | 101.45B | 103.46B | 120.09B | 120.48B | 122.97B | 22.95B | 23.15B | 23.18B | 21.54B |
| Asset Turnover | 0.31x | 0.30x | 0.29x | 0.29x | 0.29x | 0.28x | 0.26x | 0.25x | 0.25x | 0.22x | 0.22x | 0.15x | 0.79x | 0.79x | 0.79x | 0.86x |
| Asset Growth % | -34.67% | -7.36% | -2.27% | -0.19% | -3.08% | -6.45% | -1.6% | -1.94% | -13.85% | -0.32% | -2.03% | 435.9% | -0.87% | -0.13% | 7.61% | - |
| Total Current Liabilities | 8.72B | 8.78B | 7.25B | 8.04B | 9.03B | 9.06B | 8.06B | 7.88B | 7.5B | 10.15B | 9.5B | 6.93B | 4.77B | 3.41B | 3.61B | 2.57B |
| Accounts Payable | 4.48B | 4.31B | 4.19B | 4.63B | 4.85B | 4.75B | 4.3B | 4B | 4.15B | 4.36B | 4B | 2.84B | 1.54B | 1.55B | 1.56B | 1.45B |
| Days Payables Outstanding | 96.87 | 94.54 | 90.57 | 95.34 | 96.36 | 99.93 | 92.37 | 86.81 | 87.38 | 93.42 | 85.03 | 82.54 | 41.99 | 49.58 | 45.44 | 41.22 |
| Short-Term Debt | 1.38B | 1.91B | 654M | 638M | 837M | 754M | 236M | 1.03B | 398M | 3.19B | 2.69B | 83M | 1.41B | 4M | 5M | 8M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.5B | 1.46B | 1.45B | 1.78B | 2.33B | 1.94B | 2.1B | 1.81B | 1.82B | 1.49B | 1.4B | 1.57B | 996M | 860M | 1.01B | 542M |
| Current Ratio | 1.06x | 1.15x | 1.06x | 0.99x | 0.87x | 0.99x | 1.34x | 1.03x | 1.21x | 0.71x | 0.92x | 1.41x | 1.00x | 1.44x | 1.34x | 1.27x |
| Quick Ratio | 0.68x | 0.79x | 0.59x | 0.54x | 0.47x | 0.69x | 1.00x | 0.68x | 0.85x | 0.44x | 0.64x | 1.03x | 0.63x | 0.97x | 0.80x | 0.52x |
| Cash Conversion Cycle | 9.11 | 7.95 | 12.76 | 8.06 | 5.42 | -15.13 | -4.1 | 1.03 | 0.43 | -8.95 | -11.85 | 22.38 | 28.16 | 23.18 | 32.62 | 31.87 |
| Total Non-Current Liabilities | 28.09B | 31.22B | 31.71B | 32.58B | 32.62B | 34.88B | 41.53B | 41.83B | 44.18B | 43.86B | 53.41B | 49.8B | 13.81B | 14.55B | 16B | 2.38B |
| Long-Term Debt | 17.62B | 19.31B | 19.21B | 19.39B | 19.23B | 21.06B | 28.07B | 28.22B | 30.77B | 28.31B | 29.71B | 25.15B | 8.63B | 9.98B | 9.97B | 27M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 35.02B | 9.02B | 9.68B | 10.2B | 10.15B | 10.54B | 11.46B | 11.88B | 12.2B | 14.04B | 20.85B | 21.5B | 340M | 662M | 138M | 1.59B |
| Other Non-Current Liabilities | 1.46B | 1.56B | 1.44B | 1.56B | 1.75B | 1.75B | 1.99B | 1.73B | 1.21B | 1.51B | 2.84B | 3.16B | 4.84B | 3.91B | 5.9B | 758M |
| Total Liabilities | 36.94B | 40B | 38.96B | 40.62B | 41.64B | 43.94B | 49.59B | 49.7B | 51.68B | 54.02B | 62.91B | 56.74B | 18.58B | 17.96B | 19.61B | 4.95B |
| Total Debt | 19B | 21.22B | 19.87B | 20.03B | 20.07B | 21.82B | 28.31B | 29.24B | 31.17B | 31.5B | 32.4B | 25.23B | 10.03B | 9.98B | 9.97B | 35M |
| Net Debt | 16.58B | 18.6B | 18.54B | 18.63B | 19.03B | 18.37B | 24.89B | 26.96B | 30.04B | 29.87B | 28.2B | 20.4B | 8.74B | 8.29B | 8.72B | 35M |
| Debt / Equity | 0.53x | 0.51x | 0.40x | 0.40x | 0.41x | 0.44x | 0.56x | 0.57x | 0.60x | 0.48x | 0.56x | 0.38x | 2.30x | 1.92x | 2.79x | 0.00x |
| Debt / EBITDA | -9.51x | - | 7.55x | 3.62x | 4.39x | 4.99x | 9.14x | 7.20x | - | 4.44x | 4.67x | 7.47x | 4.41x | 2.00x | 3.22x | 0.01x |
| Net Debt / EBITDA | -8.30x | - | 7.04x | 3.37x | 4.17x | 4.20x | 8.04x | 6.64x | - | 4.21x | 4.06x | 6.04x | 3.84x | 1.66x | 2.81x | 0.01x |
| Interest Coverage | -4.06x | -4.75x | 1.94x | 4.98x | 4.22x | 1.83x | 1.74x | 2.96x | -7.82x | 5.42x | 5.36x | 1.77x | 3.90x | 9.16x | 10.51x | 720.00x |
| Total Equity | 36.13B | 41.79B | 49.33B | 49.72B | 48.87B | 49.45B | 50.24B | 51.75B | 51.78B | 66.08B | 57.57B | 66.24B | 4.37B | 5.19B | 3.57B | 16.59B |
| Equity Growth % | -57.65% | -15.28% | -0.8% | 1.74% | -1.18% | -1.57% | -2.91% | -0.06% | -21.64% | 14.77% | -13.08% | 1417.43% | -15.85% | 45.21% | -78.47% | - |
| Book Value per Share | 30.46 | 35.21 | 40.60 | 40.26 | 39.57 | 40.01 | 40.91 | 42.28 | 42.48 | 53.77 | 46.96 | 84.27 | 7.30 | 8.66 | 5.97 | 28.07 |
| Total Shareholders' Equity | 36.01B | 41.66B | 49.19B | 49.53B | 48.68B | 49.3B | 50.1B | 51.62B | 51.66B | 65.86B | 57.36B | 66B | 4.37B | 5.19B | 3.57B | 16.59B |
| Common Stock | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 12M | 0 | 0 | 0 | 0 |
| Retained Earnings | -9.29B | -4.63B | 2.17B | 1.37B | 489M | -1.68B | -2.69B | -3.06B | -4.85B | 8.49B | 588M | 0 | 1.04B | 1.28B | -206M | 0 |
| Treasury Stock | -2.65B | -2.64B | -2.22B | -1.29B | -847M | -587M | -344M | -271M | -282M | -224M | -207M | -31M | -796M | -29M | -2M | 0 |
| Accumulated OCI | -2.46B | -2.37B | -2.92B | -2.6B | -2.81B | -1.82B | -1.97B | -1.89B | -1.94B | -1.05B | -1.63B | -671M | -562M | -499M | -460M | -125M |
| Minority Interest | 124M | 125M | 140M | 196M | 192M | 154M | 140M | 126M | 121M | 213M | 216M | 231M | 0 | 0 | 0 | 0 |
Impairment-driven earnings volatility
Total assets fell from $90.3B in 2025Q1 to $73.1B in 2026Q2, a 19% decline, driven by a $9.1B goodwill impairment and portfolio divestitures, as reported in quarterly filings.
The balance sheet is contracting rapidly, with total liabilities also declining from $40.7B to $36.9B, but equity has dropped more sharply from $49.5B to $36.0B, reflecting the impairment charges. This suggests a deliberate de-risking of the asset base, but the pace of contraction may indicate ongoing portfolio reshaping rather than organic deterioration. Investors should monitor whether further impairments are likely as the company streamlines its brand portfolio.
Despite a reported D/E of 0.53, total debt of $19.0B remains substantial, and the debt-to-assets ratio has risen from 22.7% in 2024Q1 to 26.0% in 2026Q2, per balance sheet data.
The D/E ratio appears understated because equity has been eroded by impairments, masking the true leverage burden. With total debt stable around $19-21B and equity shrinking, the effective leverage is increasing, which could strain interest coverage if rates remain elevated. The company's ability to service this debt is supported by positive operating cash flow, but the trend warrants monitoring given the planned split and potential covenant pressures.
Goodwill dropped from $30.4B in 2024Q1 to $19.7B in 2026Q2, a 35% reduction, while PPE remained flat near $7.2B, indicating a shift toward a more tangible asset base, as per financial statements.
The massive goodwill write-downs reflect a reassessment of brand values, reducing the intangible-heavy balance sheet. This may indicate a more conservative valuation of acquired brands, but it also raises questions about the remaining goodwill's recoverability. The stable PPE suggests ongoing investment in manufacturing capacity, but the overall asset mix is becoming less reliant on intangibles, which could reduce future impairment risk.
Retained earnings swung from $2.4B in 2025Q1 to -$9.3B in 2026Q2, a $11.7B deterioration, driven by cumulative net losses, as reported in quarterly balance sheets.
The negative retained earnings balance is a direct consequence of the impairment charges, which have wiped out prior accumulated profits. This reduces the equity cushion and may limit financial flexibility, though the company continues to pay dividends, suggesting management views the losses as non-cash and temporary. The equity quality is now weaker, and future profitability will be critical to rebuilding retained earnings.
The current ratio fell from 1.31 in 2025Q1 to 1.06 in 2026Q2, while cash declined from $2.1B to $2.4B, indicating a thinner buffer against short-term obligations, per recent filings.
Liquidity is adequate but tightening, with the current ratio approaching the 1.0 threshold, which could signal difficulty covering short-term liabilities if working capital deteriorates further. Cash levels have been volatile, ranging from $0.9B to $3.5B, and the company's ability to generate operating cash flow remains positive, but the planned split may require additional liquidity. Investors should monitor whether the company can maintain its dividend and fund restructuring without increasing debt.
The reported D/E of 0.53 is misleading because equity has been reduced by $13.5B in cumulative impairments, masking the true leverage, as evidenced by the $19B debt load, per balance sheet data.
The headline leverage metrics understate the company's financial risk because the equity base has been eroded by non-cash charges, making the D/E ratio appear artificially low. If impairments were excluded, the D/E would be significantly higher, potentially exceeding 0.8, which would place KHC at a leverage disadvantage relative to peers like GIS and CPB. This distortion suggests that investors should focus on debt-to-EBITDA and interest coverage rather than D/E when assessing credit risk.
Quick answers to the most common questions about buying KHC stock.
As of 2025, The Kraft Heinz Company (KHC) had total assets of $81.79B including $10.13B in current assets.
The Kraft Heinz Company (KHC) carries total debt of $21.22B, offset by $3.67B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
The Kraft Heinz Company (KHC) has total shareholders' equity (book value) of $41.66B ($35.21 book value per share). Book value represents the net worth of the company belonging to common stock holders.
The Kraft Heinz Company (KHC) reported a current ratio of 1.15x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.